HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Alsaad, K O Articles by Herzenberg, A M Search for Related Content PubMed PubMed Citation Articles by Alsaad, K O Articles by Herzenberg, A M Pubmed/NCBI databases Medline Plus Health Information Diabetic Kidney Problems

Distinguishing diabetic nephropathy from other causes of glomerulosclerosis: an update

Department of Laboratory Medicine and Pathobiology, University of Toronto, University Health Network, Toronto, Ontario, Canada

Correspondence to:
Dr A M Herzenberg
Princess Margaret Hospital, UHN, Room 4-302, 610 University Avenue, Toronto, Canada, M5G 2M9; andrew.herzenberg{at}uhn.on.ca
ABSTRACT
Diabetic nephropathy is a common cause of end-stage renal disease worldwide. It is characterised by diffuse or nodular glomerulosclerosis, afferent and efferent hyaline arteriolosclerosis, and tubulointerstitial fibrosis and atrophy. Diffuse and nodular diabetic glomerulosclerosis share similar histological features with other clinical conditions. Immunofluorescence and electron microscopy studies, and clinicopathological correlation are essential to differentiate diabetic nephropathy from other conditions that result in diffuse and nodular glomerulosclerosis.